ROYAL BANK OF CANADA - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$105,000
+40.0%
6,923
-31.1%
0.00%
Q2 2022$75,000
-13.8%
10,049
+5.0%
0.00%
Q1 2022$87,000
-17.9%
9,575
-37.2%
0.00%
Q4 2021$106,000
+211.8%
15,255
+413.8%
0.00%
Q3 2021$34,000
+70.0%
2,969
+134.5%
0.00%
Q2 2021$20,000
-67.2%
1,266
-63.4%
0.00%
Q1 2021$61,000
+84.8%
3,461
+45.2%
0.00%
Q4 2020$33,000
+22.2%
2,384
+2.4%
0.00%
Q3 2020$27,000
-25.0%
2,327
-5.5%
0.00%
Q2 2020$36,000
-16.3%
2,462
-22.1%
0.00%
Q1 2020$43,000
-78.3%
3,160
-61.5%
0.00%
Q4 2019$198,000
+40.4%
8,200
+11.7%
0.00%
Q3 2019$141,000
-89.9%
7,339
-84.5%
0.00%
Q2 2019$1,398,000
+68.8%
47,327
+171.6%
0.00%
Q1 2019$828,000
+24.9%
17,426
-5.1%
0.00%
Q4 2018$663,000
-46.1%
18,363
-8.2%
0.00%
-100.0%
Q3 2018$1,231,000
-34.7%
19,999
-28.4%
0.00%0.0%
Q2 2018$1,886,000
+5.7%
27,927
-15.1%
0.00%0.0%
Q1 2018$1,784,000
-1.7%
32,875
+8.3%
0.00%0.0%
Q4 2017$1,815,000
-6.2%
30,364
-23.7%
0.00%0.0%
Q3 2017$1,935,000
-52.5%
39,819
-48.6%
0.00%
-50.0%
Q2 2017$4,071,000
+0.8%
77,462
-13.0%
0.00%0.0%
Q1 2017$4,040,000
+12.1%
89,083
-6.5%
0.00%0.0%
Q4 2016$3,605,000
+3.3%
95,259
+3.0%
0.00%0.0%
Q3 2016$3,489,000
+99.4%
92,442
-7.0%
0.00%
+100.0%
Q2 2016$1,750,000
+40.3%
99,451
-3.0%
0.00%0.0%
Q1 2016$1,247,000
-46.7%
102,553
+6.8%
0.00%
-50.0%
Q4 2015$2,339,000
+47.9%
96,067
+7.8%
0.00%
+100.0%
Q3 2015$1,581,000
-2.4%
89,112
-2.9%
0.00%0.0%
Q2 2015$1,620,000
-49.9%
91,796
-11.0%
0.00%
-50.0%
Q1 2015$3,231,000
+45.1%
103,095
+35.1%
0.00%
+100.0%
Q4 2014$2,227,000
+71.8%
76,308
+21.8%
0.00%0.0%
Q3 2014$1,296,000
+747.1%
62,656
+914.7%
0.00%
Q2 2014$153,000
-83.1%
6,175
-85.5%
0.00%
-100.0%
Q1 2014$905,000
+18000.0%
42,727
+15437.1%
0.00%
Q4 2013$5,0002750.00%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders